Skip to content

Rhythm Pharmaceuticals, Inc. RYTM Change in Inventories

Change in Inventories at other companies

Eli Lilly logo
Eli LillyLLY
$1.17B+86.3%
Alkermes logo
AlkermesALKS
$6.43M+267%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$7.05M+121%
TG Therapeutics logo
TG TherapeuticsTGTX
$13.28M-71.3%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
LQD
Liquidia CorporationLQDA

Other financials

Income statement

See full
Revenue$60.1M+83.8%
Gross profit$53.0M+82.3%
Operating income-$52.4M-11.4%
Net income-$55.6M-12.4%
EPS (diluted)-$0.83-2.5%

Balance sheet

See full
Cash & equivalents$62.1M-41.4%
Total debt$112.3M-1.1%
Total equity$122.9M+549%
Total assets$442.3M+14.4%

Cash flow

See full
Operating cash flow-$44.2M-9.5%
CapEx$238.3K
Free cash flow-$29.2M-2.4%

Valuation

See full
Market cap$6.64B+77.3%
Enterprise value$6.69B+78.4%
P/S30.6×+3.2×

Profitability

See full
Gross margin89.4%-0.2pp
Operating margin-90.9%-19.8pp
Net margin-93.3%-18.2pp
FCF margin-61.5%-14.1pp

Returns & leverage

See full
Return on equity-285.8%-68.9pp
Debt / equity0.9×-5.1×
Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s change in inventories?
Rhythm Pharmaceuticals, Inc. (RYTM) reported change in inventories of $3.09M in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s change in inventories changed year-over-year?
Rhythm Pharmaceuticals, Inc.'s change in inventories increased by 436.7% year-over-year, from $575K to $3.09M.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s change in inventories?
Over 3 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s change in inventories has grown at a 797.5% compound annual growth rate (CAGR), from $11K to $7.95M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.